(Q33369667)
Statements
1 reference
Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma (English)
1 reference
Kensei Tobinai
1 reference
Takashi Watanabe
1 reference
Shoji Terui
1 reference
Kuniaki Itoh
1 reference
Takashi Terauchi
1 reference
Tadahiko Igarashi
1 reference
Noriko Usubuchi
1 reference
Masanobu Nakata
1 reference
Shigeru Nawano
1 reference
Naohiro Sekiguchi
1 reference
Shigeru Kusumoto
1 reference
Kazuki Tanimoto
1 reference
Keigo Endo
1 reference
Taku Seriu
1 reference
Masaki Hayashi
1 reference
1 December 2005
1 reference
1 reference
96
1 reference
12
1 reference
903-910
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference